- DNA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
Ginkgo Bioworks (DNA) S-8Registration of securities for employees
Filed: 19 Oct 22, 5:14pm
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2021 Incentive Award Plan and 2022 Inducement Plan of Ginkgo Bioworks Holdings, Inc. of our report dated March 29, 2022, with respect to the consolidated financial statements of Zymergen Inc. (the “Company”), included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
San Mateo, California
October 19, 2022
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.